Author

Marc Moore

Royal Holloway University of LondonPrimary ORCID profile (0000-0002-3322-6159 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Marc MooreiD1 paper · Teesside University

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Casey A. MaguireiD· 1 shared DEEANN E. WALLISiD· 1 shared Erik Westin· 1 shared Hui Liu· 1 shared Kimia Rayat-Sanati· 1 shared Linda J. PopplewelliD· 1 shared Miguel Sena‐EstevesiD· 1 shared Robert A. KestersoniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Casey A. MaguireORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preclinical translation of Neurofibromatosis type 1 (NF1) exon 17 skipping using targeted U7-SnRNA packaged into engineered AAV serotypes.

Marc Moore, Kimia Rayat-Sanati, Xiaoxia Zhang, Hui Liu, Zakaria Rostamitehrani, Tarah Vijayasarathy, Erik Westin, Miguel Sena‐Esteves, Casey A. Maguire, Robert A. Kesterson, Linda J. Popplewell, DEEANN E. WALLIS

This paper evaluates AAV serotypes for delivering U7-SnRNA to induce NF1 exon 17 skipping in mice, finding AAV-F is most effective in brain and AAV-B1 in sciatic nerve.

bioRxiv · Jul 2, 2026 · PreprintGenetics